Get the Stockscreener App
1.79
1.65%
-0.03
Tiziana Life Sciences Ltd stock is traded at $1.79, with a volume of 212.83K.
It is down -1.65% in the last 24 hours and down -7.73% over the past month.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
See More
Previous Close:
$1.82
Open:
$1.75
24h Volume:
212.83K
Relative Volume:
0.66
Market Cap:
$209.16M
Revenue:
-
Net Income/Loss:
$-13.73M
P/E Ratio:
-13.77
EPS:
-0.13
Net Cash Flow:
$-3.92M
1W Performance:
+5.92%
1M Performance:
-7.73%
6M Performance:
+13.29%
1Y Performance:
+89.42%
1-Day Range:
$1.71
$1.82
1-Week Range:
$1.53
$1.83
52-Week Range:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Name
Tiziana Life Sciences Ltd
Sector
Industry
Phone
-
Address
-
Compare TLSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.79 | 216.26M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Dec-17-18 | Initiated | Laidlaw | Buy |
Tiziana Life Sciences Ltd Stock (TLSA) Latest News
Ready to Jump After Recent Trade: Tiziana Life Sciences Ltd (TLSA) - Setenews
Tiziana Life Sciences Ltd (TLSA) -5.3% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Small cap wrap: Tiziana Life Sciences, Pinnacle Silver & Gold, Rainbow Rare Earths... - Proactive Investors
Phase 2 Trial of Tiziana Life Sciences' Foralumab Gains MyMatch Program Inclusion - GuruFocus
Tiziana Life Sciences’ Phase 2 foralumab trial joins Healey ALS MyMatch Program - Proactive financial news
Tiziana Life Sciences' Foralumab Phase 2 Trial for ALS Accepted into ALS MyMatch Program at Mass General Brigham - Quiver Quantitative
Tiziana (Nasdaq: TLSA) Phase 2 nasal foralumab ALS trial joins Healey ALS MyMatch - Stock Titan
Is Tiziana Life Sciences Ltd a good long term investmentStop Loss Placement Tips & Reap the Rewards of Patience + Planning - earlytimes.in
Will Tiziana Life Sciences Ltd stock benefit from sector rotation - newser.com
Will Tiziana Life Sciences Ltd stock reach all time highs in 20252025 Performance Recap & AI Driven Stock Reports - newser.com
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.5% – Here’s Why - Defense World
Will Tiziana Life Sciences Ltd stock outperform Nasdaq indexDollar Strength & Daily Profit Focused Screening - newser.com
3 Promising Penny Stocks With At Least $40M Market Cap - Yahoo Finance
Reversal indicators forming on Tiziana Life Sciences Ltd stockAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Applying chart zones and confluence areas to Tiziana Life Sciences Ltd - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than marketOil Prices & AI Forecast Swing Trade Picks - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exitWeekly Profit Recap & AI Driven Price Forecasts - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investorsTreasury Yields & Long-Term Growth Plans - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Is Tiziana Life Sciences Ltd stock a buy before product launches2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com
Is Tiziana Life Sciences Ltd stock entering bullish territoryQuarterly Trade Review & Reliable Entry Point Alerts - newser.com
Is Tiziana Life Sciences Ltd stock oversold or undervaluedJuly 2025 Snapshot & AI Driven Price Predictions - Fundação Cultural do Pará
Tiziana Life Sciences Ltd (TLSA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Using portfolio simulators with Tiziana Life Sciences Ltd includedEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Tiziana Life Sciences Ltd. R (0RP.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tiziana Life Sciences to present clinical pipeline at Jefferies London Healthcare Conference - Proactive Investors
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference - The Manila Times
Tiziana Life Sciences to Present Innovative Pipeline and Foralumab Update at Jefferies London Healthcare Conference - Quiver Quantitative
Tiziana Life Sciences Ltd Stock (TLSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
2.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):